Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meihua Tu

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 14, 2009
Pyridones as glucokinase activators: identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycleJeffrey A Pfefferkorn, Jihong Lou, Martha L Minich, et al.
Scientific Reports|December 10, 2016
Chiral Sulfoxide-Induced Single Turn Peptide α-HelicityQingzhou Zhang, Fan Jiang, Bingchuan Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2014
Identification of a novel conformationally constrained glucagon receptor antagonistEsther C Y Lee, Meihua Tu, Benjamin D Stevens, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2011
A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicityKevin J Filipski, Jianwei Bian, David C Ebner, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2023
Small molecule inhibitors of PCSK9. SAR investigations of head and amine groupsGary E Aspnes, Steven B Coffey, Etzer Darout, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitusAngel Guzman-Perez, Jeffrey A Pfefferkorn, Esther C Y Lee, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2010
Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2Jeffrey W Corbett, Kevin D Freeman-Cook, Richard Elliott, et al.
Chemistry & Biology|January 21, 2014
Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitroChristina I Schroeder, Joakim E Swedberg, Jane M Withka, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2015
Discovery of spirocyclic-diamine inhibitors of mammalian acetyl CoA-carboxylaseDaniel W Kung, David A Griffith, William P Esler, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motifKevin J Filipski, Angel Guzman-Perez, Jianwei Bian, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|May 14, 2009
Pyridones as glucokinase activators: identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycleJeffrey A Pfefferkorn, Jihong Lou, Martha L Minich, et al.
Scientific Reports|December 10, 2016
Chiral Sulfoxide-Induced Single Turn Peptide α-HelicityQingzhou Zhang, Fan Jiang, Bingchuan Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2014
Identification of a novel conformationally constrained glucagon receptor antagonistEsther C Y Lee, Meihua Tu, Benjamin D Stevens, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2011
A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicityKevin J Filipski, Jianwei Bian, David C Ebner, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2023
Small molecule inhibitors of PCSK9. SAR investigations of head and amine groupsGary E Aspnes, Steven B Coffey, Etzer Darout, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2013
The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitusAngel Guzman-Perez, Jeffrey A Pfefferkorn, Esther C Y Lee, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2010
Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2Jeffrey W Corbett, Kevin D Freeman-Cook, Richard Elliott, et al.
Chemistry & Biology|January 21, 2014
Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitroChristina I Schroeder, Joakim E Swedberg, Jane M Withka, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2015
Discovery of spirocyclic-diamine inhibitors of mammalian acetyl CoA-carboxylaseDaniel W Kung, David A Griffith, William P Esler, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motifKevin J Filipski, Angel Guzman-Perez, Jianwei Bian, et al.
Pageof 5